Acalabrutinib-d4 - HY-17600S
Nur noch %1 verfügbar
Catalog #
HY-17600S
Ab
206,40 €
Regular Price
258,00 €
Acalabrutinib-d4 (ACP-196-d4) is a deuterium labeled Acalabrutinib. Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor[1]. Acalabrutinib-d4 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-17600S/Acalabrutinib-d4-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | ACP-196-d4 |
| CAS | 2699608-18-7 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 469.53 |
| Solubility | 10 mM in DMSO|DMSO : 250mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Btk |
| Application: | Cancer-Kinase/protease |
|---|